As the global pharmaceutical sector faces intensifying regulatory scrutiny and cost pressure, the industry’s tolerance for inefficiency is evaporating. From Phase I R&D to full-scale commercial production, accurate tablet and capsule weight control is no longer a matter of compliance — it’s a strategic lever for product integrity, yield, and operational efficiency.
According to McKinsey, pharmaceutical companies lose up to 5% of their finished product to inefficiencies in manufacturing, much of which is avoidable through better in-process controls. In parallel, regulators are tightening focus on data integrity and traceability, particularly in light of FDA and EMA harmonisation efforts under ICH Q13 and Q14 guidelines.
For forward-thinking pharmaceutical manufacturers, the shift is clear: legacy weight checking approaches — often fragmented, labour-intensive, or siloed from digital QC systems — no longer pass muster.
This is where high-precision weight sorters purpose-built for modern pharma come into play. Setting the benchmark for precision in process, and fully compliant with 21 CFR Part 11, our next-generation weight sorters deliver market-leading accuracy at throughputs that make sense for both labs and batch manufacturing. For R&D environments, the same platform enables early-stage development teams to rapidly characterise, screen, and validate new formulations — all while generating the structured data regulators increasingly expect.
In short, pharmaceutical companies under pressure to do more with less are starting to re-evaluate every gram. And in doing so, they're discovering that the right precision weight sorter isn’t a cost — it’s a multiplier of yield, compliance, and confidence.
For more information, please visit https://www.ciprecision.com/products/sp-range/ or contact us at sales@ciprecision.com to find out how we can help.
